Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biohaven (BHVN) Short-term Investments (2022 - 2026)

Biohaven has reported Short-term Investments over the past 5 years, most recently at $74.7 million for Q1 2026.

  • Quarterly results put Short-term Investments at $74.7 million for Q1 2026, down 66.68% from a year ago — trailing twelve months through Mar 2026 was $74.7 million (down 66.68% YoY), and the annual figure for FY2025 was $89.2 million, down 76.95%.
  • Short-term Investments reached $74.7 million in Q1 2026 per BHVN's latest filing, down from $89.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $386.9 million in Q4 2024 and bottomed at $40.4 million in Q2 2023.
  • Median Short-term Investments over the past 5 years was $165.6 million (2023), compared with a mean of $179.2 million.
  • The largest annual shift saw Short-term Investments skyrocketed 389.42% in 2024 before it tumbled 76.95% in 2025.
  • Over 5 years, Short-term Investments stood at $260.5 million in 2022, then tumbled by 48.78% to $133.4 million in 2023, then surged by 189.96% to $386.9 million in 2024, then crashed by 76.95% to $89.2 million in 2025, then dropped by 16.19% to $74.7 million in 2026.
  • Business Quant data shows Short-term Investments for BHVN at $74.7 million in Q1 2026, $89.2 million in Q4 2025, and $75.4 million in Q3 2025.